Machine Learning in Neonatal Respiratory Distress Syndrome: From Early Warning to Clinical Translation.
Authors
Affiliations (6)
Affiliations (6)
- Department of Pediatrics, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
- Department of Pediatric Cardiology, Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
- Department of Otolaryngology, Dr. Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Hematology and Oncology Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Abstract
Neonatal respiratory distress syndrome (NRDS), driven by pulmonary surfactant deficiency in preterm infants, is a leading cause of neonatal morbidity and mortality. This narrative review synthesises machine learning (ML) applications across the NRDS spectrum-from prenatal risk stratification to long-term complication prediction-appraised against the TRIPOD+AI (2024) framework. Reported discrimination is high but heterogeneous (AUC 0.78-0.99); the most robust estimate is the prospective Korean Neonatal Network study of 13,087 very-low-birthweight infants across 76 hospitals (full-model AUROC 0.9187; testing 0.9216). Ensemble methods and deep-learning architectures tend to outperform logistic regression, often by modest margins. Emerging modalities-lung-ultrasound radiomics, cry-signal analysis (∼95% accuracy, controlled datasets), and ATR-FTIR spectroscopy-remain research-stage. Reporting deficits are near-universal: <20% report calibration, none conduct prospective fairness audits, <15% release code. Clinical translation requires federated-learning consortia, explainable AI, prospective external validation, and structured implementation science.